Bruker Daltonics announced today that it has established a collaboration
with the Mass Spectrometry Resource laboratory of Professor Catherine
Costello at the Boston University School of Medicine (BUSM).
The collaborative effort will focus on the application of high
performance ion trap mass spectrometry and Fourier Transform Mass
Spectrometry (FTMS) to glycomics and proteomics applications. The
researchers at the Boston University School of Medicine are already
using the recently introduced Bruker amaZonTM
ion trap mass spectrometer for detailed and high throughput analyses
of glycan structures, and have just ordered a solariXTM
FTMS with a 12 Tesla magnet for high performance bottom-up and
top-down proteomics and glycomics with ETD and ECD capabilities.
Professor Costello is a Research Professor of Biochemistry, Biophysics
and Chemistry, and the Director of the BUSM
Center for Biomedical Mass Spectrometry. Her laboratory is a
resource center sponsored by the NIH where mass spectrometry is applied
to the study of biopolymers (proteins, carbohydrates and lipids) by
local, national and international collaborators. The recent award of an
NIH-NCRR High-End Shared Instrumentation Grant to the BUSM Center
provided the funds for purchase of the solariX. Professor
Costello and her group are recognized internationally as experts in the
analysis of the complex structures of carbohydrates and their
conjugates, such as glycoproteins and glycolipids. While these important
classes of molecules are involved in immune system recognition, nervous
system development, and many other critical biological processes,
methods for their full structural characterization are less developed
than for linear biopolymers such as proteins and oligonucleotides. Not
only are the structures of carbohydrates more complex, because of their
non-linear, branched structures, but they usually occur in complex
mixtures.
The recently introduced Bruker solariX FTMS provides the
highest mass resolving power and mass accuracy available on any mass
spectrometer, making it ideally suited to tackle extremely complex
mixtures. Additionally, the solariX offers the most
versatile suite of tools for fragmenting biopolymers, including
Collision Induced Dissociation (CID), either in the front-end collision
cell and/or in the ICR cell, as well as Electron Capture Dissociation
(ECD) in the ICR cell, and now even front-end Electron Transfer
Dissociation (ETD).